August 6th- Beyond the webinar- Preventing Relapse After Allogeneic Transplantation in High-Risk Myeloid Malignancies: Are We Entering the Era of Precision Post-Transplant Care?

CME Congresses .

August 6th- Beyond the webinar- Preventing Relapse After Allogeneic Transplantation in High-Risk Myeloid Malignancies: Are We Entering the Era of Precision Post-Transplant Care?

July 23rd- Beyond the webinar- EHA ASCO 2026 Highlights in AML and MDS

CME Congresses .

July 23rd- Beyond the webinar- EHA ASCO 2026 Highlights in AML and MDS

August 4th- Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

CME Congresses .

August 4th- Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

August 12th- The All-Oral Combination of Revumenib, Decitabine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia (SAVE)

CME Congresses .

August 12th- The All-Oral Combination of Revumenib, Decitabine and Venetoclax for Relapsed or Refractory Acute Myeloid Leukemia (SAVE)

August 19th- Supportive care interventions in hematopoietic stem cell transplantation: a systematic review and meta-analysis

CME Congresses .

August 19th- Supportive care interventions in hematopoietic stem cell transplantation: a systematic review and meta-analysis

August 24th- Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Hodgkin Lymphoma: New EBMT Practice Recommendations

CME Congresses .

August 24th- Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Hodgkin Lymphoma: New EBMT Practice Recommendations

August 26th- Updated Consensus Guidelines for the Diagnosis and Management of Hairy Cell Leukemia and Hairy Cell Leukemia Variant

CME Congresses .

August 26th- Updated Consensus Guidelines for the Diagnosis and Management of Hairy Cell Leukemia and Hairy Cell Leukemia Variant

July 20th- Beyond the Webinar: Are CALR-Directed Therapies Redefining the Future of Myeloproliferative Neoplasms?

CME Congresses .

July 20th- Beyond the Webinar: Are CALR-Directed Therapies Redefining the Future of Myeloproliferative Neoplasms?

July 15th- Sonrotoclax Monotherapy After BTK Inhibitor Therapy in Mantle Cell Lymphoma

CME Congresses .

July 15th- Sonrotoclax Monotherapy After BTK Inhibitor Therapy in Mantle Cell Lymphoma

July 13th- Beyond the Webinar: CAR-T Therapy in Lymphoma: Entering a New Era of Engineering and Accessibility

CME Congresses .

July 13th- Beyond the Webinar: CAR-T Therapy in Lymphoma: Entering a New Era of Engineering and Accessibility